Abstract:In silico modeling of blood-brain barrier (BBB) permeability plays an important role in early discovery of central nervous system (CNS) drugs due to its high-throughput and cost-effectiveness. Natural products (NP) have demonstrated considerable therapeutic efficacy against several CNS diseases. However, BBB permeation property of NP is scarcely evaluated both experimentally and computationally. It is well accepted that significant difference in chemical spaces exists between NP and synthetic drugs, which calls into doubt on suitability of available synthetic chemical based BBB permeability models for the evaluation of NP. Herein poor discriminative performance on BBB permeability of NP are first confirmed using internal constructed and previously published drug-derived computational models, which warrants the need for NP-oriented modeling. Then a quantitative structure property relationship (QSPR) study on a NP dataset was carried out using four different machine learning methods including support vector machine, random forest, Naive Bayes and probabilistic neural network with 67 selected features. The final consensus model was obtained with approximate 90% overall accuracy for the cross-validation study, which is further taken to predict passive BBB permeability of a large dataset consisting of over 10,000 compounds from traditional Chinese medicine (TCM). For 32 selected TCM molecules, their predicted BBB permeability were evaluated by in vitro parallel artificial membrane permeability assay and overall accuracy for in vitro experimental validation is around 81%. Interestingly, our in silico model successfully predicted different BBB permeation potentials of parent molecules and their known in vivo metabolites. Finally, we found that the lipophilicity, the number of hydrogen bonds and molecular polarity were important molecular determinants for BBB permeability of NP. Our results suggest that the consensus model proposed in current work is a reliable tool for prioritizing potential CNS active NP across the BBB, which would accelerate their development and provide more understanding on their mechanisms, especially those with pharmacologically active metabolites. (C) 2017 Elsevier Inc. All rights reserved.

Evaluation of Drug Blood-Brain-Barrier Permeability Using a Microfluidic Chip

Microfluidic blood-brain barrier model provides in vivo-like barrier properties for drug permeability screening

In Silico Modeling on ADME Properties of Natural Products: Classification Models for Blood-Brain Barrier Permeability, Its Application to Traditional Chinese Medicine and in Vitro Experimental Validation

Development of a Blood-Brain Barrier Model in a Membrane-Based Microchip for Characterization of Drug Permeability and Cytotoxicity for Drug Screening

A perfused human blood–brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport

In Situ Surface Modification of Microfluidic Blood-Brain-Barriers for Improved Screening of Small Molecules and Nanoparticles

Microphysiological Blood‐Brain Barrier Systems for Disease Modeling and Drug Development

Blood brain barrier-on-a-chip permeation to model neurological diseases using microfluidic biosensors

Microengineered human blood–brain barrier platform for understanding nanoparticle transport mechanisms

<i>In Situ</i> Surface Modification of Microfluidic Blood-Brain-Barriers for Improved Screening of Small Molecules and Nanoparticles

Constant-rate perfused array chip for high-throughput screening of drug permeability through brain endothelium

Functional Blood-Brain Barrier Model with Tight Connected Minitissue by Liquid Substrates Culture.

Advances in modeling permeability and selectivity of the blood-brain barrier using microfluidics

Non-animal models for blood–brain barrier permeability evaluation of drug-like compounds

Predicting Blood-Brain Barrier Permeability of Drugs: Evaluation of Different In Vitro Assays

Manufactured tissue-to-tissue barrier chip for modeling the human blood-brain barrier and regulation of cellular trafficking

Modeling of Blood–Brain Barrier (BBB) Dysfunction and Immune Cell Migration Using Human BBB-on-a-Chip for Drug Discovery Research

Development of QSAR models to predict blood-brain barrier permeability

Construction of a novel blood brain barrier-glioma microfluidic chip model: Applications in the evaluation of permeability and anti-glioma activity of traditional Chinese medicine components

Development of a Novel, Physiologically Realistic Pediatric Blood Brain Barrier on a Chip

In Silico Prediction of Blood-Brain Barrier Permeability of Chemical Compounds through Molecular Feature Modeling